Free Newsletter
Mylan execs' pay leaps by 41%
Are you sick of executive-pay news yet? We admit that the dollar signs are starting to circle around our heads like the tweeting birds in vintage cartoons. Nevertheless, even we get interested when we hear about a 41 percent pay raise--average pay raise, mind you--for one company's top execs.
Who should be so lucky? The execs at Mylan, who saw their collective pay jump by 41 percent. Together, the top four brought down $22 million in 2008, up from $15.2 million in 2007, BNet Pharma reports. CFO Edward J. Borkowski got the biggest raise, at 113 percent; his pay more than doubled to $3.2 million from $1.5 million. COO Heather Bresch and global tech chief Rajiv Malik each got 70 percent increases, to $2.9 million from $1.7 million.
CEO Robert J. Coury's 20 percent increase, to $12.5 million, looks somewhat paltry in percentage terms, compared with his colleagues. But he also got to use the company aircraft for vacations and other personal travel, which is quite a nice perk.
- read the post at BNet
Related Articles:
Amid proxy fight, Biogen chief earns $11.3M
Amid turmoil, Elan chief turns down bonus
More millions for Wyeth chief Poussot
Wyeth CEO in line for $53M handshake
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: